E. coli Expression System with Gateway™ Technology
Product Image
Invitrogen™

E. coli Expression System with Gateway™ Technology

El sistema de expresión de E. coli con tecnología Gateway™ está diseñado para crear clones de expresión de E. coliMás información
Have Questions?
Número de catálogoCantidad
1182402620 reacciones
Número de catálogo 11824026
Precio (MXN)
-
Cantidad:
20 reacciones
El sistema de expresión de E. coli con tecnología Gateway™ está diseñado para crear clones de expresión de E. coli que contengan el promotor T7. Los clones de expresión están listos para la transformación y expresión en E. coli El sistema ofrece:
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Resistencia bacteriana a los antibióticosAmpicilina (AMPR)
Cepa bacteriana o de levaduraBL21-AI™
Mecanismo de expresiónExpresión basada en células
Sistema de expresiónE. coli
Tipo de productoSistema de expresión
Cantidad20 reacciones
VectorVectores Gateway T7
Método de clonaciónGateway
Línea de productosGateway
PromotorT7
Etiqueta de proteínaEtiqueta GST, Etiqueta His (6x)
Unit Size20 reactions
Contenido y almacenamiento
El sistema de expresión E. coli con tecnología Gateway™ incluye: Mezcla enzimática LR Clonase™ y tampón de reacción, vectores de destino Gateway™ pDEST™14, pDEST™15, pDEST17 y pDEST™24, solución de proteinasa K (2 µg/µl), control positivo pENTR™-gus, One Shot™ BL21-AI™ y células competentes Library Efficiency™ DH5α™. Almacene las células componentes y las mezclas enzimáticas Clonase™ a -70 °C. Almacene los vectores a -20 °C.

Preguntas frecuentes

How large of a PCR product can I recombine with a pDONR vector via BP cloning? Does the same apply for TOPO-adapted Entry vectors?

There is no theoretical limit to insert size for a BP reaction with a pDONR vector. Maximum size tested in-house is 12 kb. TOPO vectors are more sensitive to insert size and 3-5 kb is the upper limit for decent cloning efficiency.

How should I clean up my attB-PCR product?

After generating your attB-PCR product, we recommend purifying it to remove PCR buffer, unincorporated dNTPs, attB primers, and any attB primer-dimers. Primers and primer-dimers can recombine efficiently with the Donor vector in the BP reaction and may increase background after transformation into E. coli, whereas leftover PCR buffer may inhibit the BP reaction. Standard PCR product purification protocols using phenol/chloroform extraction followed by ammonium acetate and ethanol or isopropanol precipitation are not recommended for purification of the attB-PCR product as these protocols generally have exclusion limits of less than 100 bp and do not efficiently remove large primer-dimer products. We recommend a PEG purification protocol (see page 17 of the Gateway Technology with Clonase II manual). If you use the above protocol and your attB-PCR product is still not suitably purified, you may further gel-purify the product. We recommend using the PureLink Quick Gel Extraction kit.

I'm trying to propagate my Gateway destination vector and am not seeing any colonies. What should I do?

Check the genotype of the cell strain you are using. Our Gateway destination vectors typically contain a ccdB cassette, which, if uninterrupted, will inhibit E. coli growth. Therefore, un-cloned vectors should be propagated in a ccdB survival cell strain, such as our ccdB Survival 2 T1R competent cells.

What is the difference between LR Clonase II and LR Clonase II Plus?

LR Clonase II Plus contains an optimized formulation of recombination enzymes for use in MultiSite Gateway LR reactions. LR Clonase and LR Clonase II enzyme mixes are not recommended for MultiSite Gateway LR recombination reactions, but LR Clonase II Plus is compatible with both multi-site and single-site LR recombination reactions.

What is the purpose of the Proteinase K step following a Gateway LR Recombination reaction, and is it critical to the results?

When the LR reaction is complete, the reaction is stopped with Proteinase K and transformed into E. coli resulting in an expression clone containing a gene of interest. A typical LR reaction followed by Proteinase K treatment yields about 35,000 to 150,000 colonies per 20ul reaction. Without the Proteinase K treatment, up to a 10 fold reduction in the number of colonies can be observed. Despite this reduction, there are often still enough colonies containing the gene of interest to proceed with your experiment, so the Proteinase K step can be left out after the LR reaction is complete if necessary.